{"id":"dimethyltubocurarinium","rwe":[],"tags":[{"label":"metocurine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Acetylcholine receptor","category":"target"},{"label":"CHRNA1","category":"gene"},{"label":"CHRNB1","category":"gene"},{"label":"CHRND","category":"gene"},{"label":"M03AA04","category":"atc"},{"label":"Active","category":"status"},{"label":"Muscle relaxation, function","category":"indication"},{"label":"Lilly","category":"company"},{"label":"Neuromuscular Agents","category":"pharmacology"},{"label":"Neuromuscular Blocking Agents","category":"pharmacology"},{"label":"Neuromuscular Nondepolarizing Agents","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"}],"phase":"marketed","safety":{"drugInteractions":[{"url":"/drug/neomycin","drug":"neomycin","action":"Monitor closely","effect":"May interact with Metocurine Iodide, Neomycin","source":"DrugCentral","drugSlug":"neomycin"},{"url":"/drug/netilmicin","drug":"netilmicin","action":"Monitor closely","effect":"May interact with Metocurine Iodide, Netilmicin","source":"DrugCentral","drugSlug":"netilmicin"},{"url":"/drug/streptomycin","drug":"streptomycin","action":"Monitor closely","effect":"May interact with Metocurine Iodide, Streptomycin","source":"DrugCentral","drugSlug":"streptomycin"},{"url":"/drug/tobramycin","drug":"tobramycin","action":"Monitor closely","effect":"May interact with Metocurine Iodide, Tobramycin","source":"DrugCentral","drugSlug":"tobramycin"}]},"trials":[],"aliases":[],"company":"Eli Lilly","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=dimethyltubocurarinium","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:18:58.515537+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:19:03.902781+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=dimethyltubocurarinium","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:19:04.243258+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105841/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:19:05.109838+00:00"}},"allNames":"metocurine","offLabel":[],"synonyms":["trimethyltubocurarine iodide","metocurine iodide","dimethyltubocurarine","metocurine","dimethyltubocurarinium","dimethyltubocurarinium chloride"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"LILLY","regulator":"FDA"}],"brandName":"Metocurine","ecosystem":[{"indication":"Muscle relaxation, function","otherDrugs":[{"name":"atracurium","slug":"atracurium","company":""},{"name":"cisatracurium","slug":"cisatracurium","company":"Abbvie"},{"name":"doxacurium","slug":"doxacurium","company":""},{"name":"mivacurium","slug":"mivacurium","company":"Abbvie"}],"globalPrevalence":null}],"mechanism":{"target":"Acetylcholine receptor","novelty":"First-in-class","targets":[{"gene":"CHRNA1","source":"DrugCentral","target":"Acetylcholine receptor","protein":"Acetylcholine receptor subunit alpha"},{"gene":"CHRNB1","source":"DrugCentral","target":"Acetylcholine receptor","protein":"Acetylcholine receptor subunit beta"},{"gene":"CHRND","source":"DrugCentral","target":"Acetylcholine receptor","protein":"Acetylcholine receptor subunit delta"},{"gene":"CHRNA2","source":"DrugCentral","target":"Neuronal acetylcholine receptor; alpha2/beta2","protein":"Neuronal acetylcholine receptor subunit alpha-2"},{"gene":"CHRNB2","source":"DrugCentral","target":"Neuronal acetylcholine receptor; alpha2/beta2","protein":"Neuronal acetylcholine receptor subunit beta-2"}],"modality":"Small Molecule","drugClass":"metocurine","explanation":"","oneSentence":"","technicalDetail":"Metocurine is a competitive antagonist of the nicotinic acetylcholine receptor, specifically targeting the α1, α2, α3, α7, and β2 subunits. By binding to these subunits, metocurine prevents acetylcholine from activating the receptor, leading to a decrease in muscle contraction and relaxation of the muscle."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/908","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=dimethyltubocurarinium","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:39:51.580184","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:19:06.895658+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"tubocurarine","drugSlug":"tubocurarine","fdaApproval":"1945-02-20","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"dimethyltubocurarinium","indications":{"approved":[{"name":"Muscle relaxation, function","source":"DrugCentral","snomedId":11977004,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"tubocurarine","brandName":"tubocurarine","genericName":"tubocurarine","approvalYear":"1945","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000145837","MMSL":"5100","NDDF":"002401","UNII":"O0U0E87X7F","VUID":"4017449","CHEBI":"CHEBI:6900","VANDF":"4017449","RXNORM":"203206","UMLSCUI":"C0700566","chemblId":"CHEMBL2105841","ChEMBL_ID":"CHEMBL1259","KEGG_DRUG":"D00761","DRUGBANK_ID":"DB00416","PDB_CHEM_ID":" CU9","PUBCHEM_CID":"21233","SNOMEDCT_US":"1325004","SECONDARY_CAS_RN":"7601-55-0","MESH_SUPPLEMENTAL_RECORD_UI":"C032943"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Eli Lilly","relationship":"Original Developer"}],"pharmacokinetics":{"source":"DrugCentral","halfLife":"5.1 hours","clearance":"1.2 mL/min/kg","fractionUnbound":"0.65%","volumeOfDistribution":"0.4 L/kg"},"publicationCount":0,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"M03AA04","allCodes":["M03AA04"]},"biosimilarFilings":[],"originalDeveloper":"Lilly","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Eli Lilly","companyId":"eli-lilly","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"LILLY","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"LILLY","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":"LILLY","brand_name_local":null,"application_number":null},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":null,"mah":"LILLY","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"LILLY","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":"LILLY","brand_name_local":null,"application_number":null},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:19:06.895658+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}